Abiomed, Inc. (Abiomed), a cardiovascular devices company, has appointed Michael Howley as vice president and general manager, global sales and marketing of the company. Before joining Abiomed, Howley spent 20 years at GE Healthcare. From 2006 to 2009, Howley was general manager at GE Healthcare, overseeing the Americas X-ray and Interventional Radiology division, with revenues over $400 million.
Howley brings over 20 years of healthcare sales and marketing management experience, as well as a highly successful background in commercial sales achievements at General Electric Healthcare, with expertise in leading varying sizes of healthcare businesses ranging from X-ray imaging, PET/CT, ultrasound, Lunar bone densitometers to clinical information software systems.
In his role at GE Healthcare, Howley developed strategic marketing campaigns directed to drive sales and X-ray portfolio adoption. In this role, Howley led the business to grow revenues and gain significant market share each year.
Howley also held the general manager roles for the clinical information systems at GE, a $200 million healthcare software division, where he drove the business strategy, messaging and strategic vision. Earlier, he was the Americas sales manager of functional and molecular imaging, where he led a hybrid model of sales specialists, a paradigm that was new to GE. In this position, Howley helped achieve order growth by 30% for a new imaging platform, which translated into a significant increase in market share and gross margin. Prior to this role, he held several other national and regional sales roles at GE, beginning his tenure with the company in 1989.
Howley received a bachelor’s degree in business administration and marketing from Auburn University.
“We are extremely pleased to welcome Mike to the management team. He has a proven track record of success across several healthcare technology markets and has been formally recognized and commended for his superior leadership in nearly every position he has held,” said Michael R. Minogue, chairman, president and chief executive officer of Abiomed. “An experienced senior executive, Mike has demonstrated his ability to grow revenue, gross margin, and market share, while adapting to different distribution models and technologies. He will be a highly capable contributor to the further adoption and utilization of our heart recovery technologies.”
“I am thrilled to join the leadership team at Abiomed as we expand the presence of Impella in the catherization lab,” said Howley. “The Company is experiencing rapid growth and I am looking forward to implementing a sales strategy focused on establishing new customer accounts while driving utilization.”